Latest news

16/04/2020

Gemeinsames DKTK-Patientenregister

DKTK scientists from all DKTK partner sites are establishing a common clinical data platform to collect information from tumor patients suffering from COVID-19 or patients, who have been tested for…

02/04/2020

Brain tumors in children: Hereditary genetic defect destabilizes protein regulation

The causes of 40 percent of all cases of certain medulloblastoma – dangerous brain tumors affecting children – are hereditary. These are the findings of a recent genetic analysis carried out by…

24/03/2020

DKFZ researchers in the fight against the COVID-19 pandemic

Scientists at the German Cancer Research Center (DKFZ) are playing an active part in the battle against the COVID-19 pandemic and have set up a task force called fightCOVID@DKFZ. In collaboration with…

03/03/2020

A new approach in leukemia research: Glucose deprivation stops malignant transformation of blood cells

Leukemia is caused by uncontrolled proliferation of immature blood cells. Cell growth requires a lot of energy, which comes primarily from glycolysis. In a research project funded by the Wilhelm…

25/02/2020

The most comprehensive map to date of the cancer genome published

The great hope of precision oncology is to be able to recommend effective drugs to cancer patients based on an analysis of their tumor genome. Recommendations like these must draw on careful…

24/02/2020

German Cancer Prize awarded to Andreas Trumpp

Identifying cancer stem cells in different types of cancer, finding their weak points, and using these results to counter the spread of tumors and curb their resistance to treatment are the goals DKTK…

22/01/2020

Together against common diseases: DZG Symposium in Dresden

The second joint symposium of the German Centers for Health Research (DZG), the German Center for Diabetes Research (DZD), the German Cancer Consortium (DKTK), the German Center for Neurodegenerative…

19/12/2019

Armed antibodies for cancer immunotherapy: DKFZ and DKTK scientists granted patent for innovative antibody design

Scientists from the German Cancer Consortium (DKTK) and the German Cancer Research Center (DKFZ) at Tübingen University Hospital have managed to attach immunostimulatory cytokines to cancer-specific…

17/12/2019

First map of circular DNA in childhood cancer

Press release by the Charité Berlin. Cancer development is associated with the gradual accumulation of DNA defects over time. Thus, cancer is considered an age-related disease. But why do children…

05/12/2019

Better understanding the development of aggressive embryonic brain tumors

Scientists from the Hopp Children's Cancer Center Heidelberg (KiTZ) and the German Cancer Consortium (DKTK) present the most comprehensive analyses of a group of particularly aggressive brain tumors…

22/10/2019

Bispecific antibody to be tested for treatment of prostate cancer

A press release by the Universitätsklinikum Tübingen. Prostate carcinoma is the most common type of cancer in men. If the tumor metastasizes, it is not curable by established treatment…

17/10/2019

Cancer Core Europe Summer School 2019 – Emerging talent in the field of cancer research

At the Summer School for Translational Cancer Research in Albufeira, Portugal, from 7 to 11 October, young physicians and scientists came together to discuss topical issues in cancer medicine and to…

07/10/2019

Influential fusion partner of a new cancer-driver protein

Cancer treatments are increasingly making use of drugs that target cancer-driver mutations. In many types of cancer, a driver mutation is found in the region of the BRAF gene. Researchers from the…

12/09/2019

Machine learning improves the diagnosis of patients with head and neck cancers

Joint press release by Charité – Universitätsmedizin Berlin and Technische Universität Berlin. Researchers from Charité – Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have…

26/07/2019

Precision medicine and transgene T cells: 6th Munich Cancer Retreat in Herrsching am Ammersee

„An exciting overview over the field of precision oncology” was given by Christophe Le Tourneau, lead of landmark trials such as SHIVA 01 and 02 as mentioned by Michael von Bergwelt (deputy…

18/07/2019

Making cancer stem cells visible to the immune system - New results may enable innovative treatment concept against leukemia

Joint press release of the German Cancer Research Center (DKFZ), the German Cancer Consortium (DKTK), and the University Hospital Tübingen. Leukemia stem cells protect themselves against the immune…

24/06/2019

Focus on BAP1 for the diagnosis and therapy of kidney cancer and uveal melanoma

Introducing Samuel Peña-Llopis at DKTK Essen/Düsseldorf Samuel Peña-Llopis is leading the new young investigator group for Translational Genomics in Solid Tumors at the partner site Essen/Düsseldorf…

13/06/2019

Not silent at all

The so-called "silent" or "synonymous" genetic alterations do not result in altered proteins. But they can nevertheless influence numerous functions of the cell and thus also disease processes.…

05/06/2019

Stomach and colorectal cancer: Identifying patients at an early stage who are suitable for artificial intelligence immunotherapy.

Press release of the NCT Heidelberg. Changes in certain sections of the genetic material of cancer cells, so-called microsatellites, can provide an important indication of whether immunotherapy…

29/04/2019

Fighting colon cancer with killer cells

Genetically modified immune cells can successfully destroy colon cancer cells. This has been demonstrated for the first time by scientists from the German Cancer Consortium (DKTK) at Georg Speyer…